LEO Pharma is committed to improving and maintaining the quality of care for people living with dermatological (skin) and thromboembolic (blood clotting) conditions, and to increasing awareness and understanding within these areas.
We strive to develop treatments that deliver value to people and societies around the world. Adapting quickly to new demands, we research and develop innovative and effective medicines aiming to fulfil unmet treatment needs.
Patient well-being drives everything we do. We are constantly researching to provide new treatment options and methods of delivery so healthcare professionals can provide the best possible care for their patients, whether this is once-daily treatment, fast symptom resolution or therapies that suit different lifestyle requirements.
As well as cutting edge treatments, we know it is important to provide education and holistic support for people living with serious or chronic conditions. As such, LEO Pharma UK/Ireland (UK/IE) is proud to have developed leading-edge support programmes, including online resources to help improve the lives of people living with psoriasis.
Thanks to the LEO Foundation, LEO Pharma is able to offer a long-term commitment to people with life-changing conditions, their healthcare professionals and associated patient support organisations.